Source: EURLEX
Language: en
Format: md

201806220751970242018/C 240/703212018TC24020180709EN01ENINFO\_JUDICIAL20180518616111

Case T-321/18: Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)

[Top](#document1)

C2402018EN6110120180518EN0070611611

Action brought on 18 May 2018 — Serenity Pharmaceuticals v EUIPO — Gebro Holding (NOCUVANT)

(Case T-321/18)

2018/C 240/70Language in which the application was lodged: English

Parties

Applicant: Serenity Pharmaceuticals LLC (Milford, Pennsylvania, United States) (represented by: J. Day, Solicitor)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Gebro Holding GmbH (Fieberbrunn, Austria)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Trade mark at issue: EU word mark NOCUVANT — Application for registration No 13 053 434

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 8 March 2018 in Case R 584/2017-2

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |

| — | annul the decision of the Opposition Division of 27 January 2018 in Opposition No. B 002437922; |

| — | order EUIPO and Gebro Holdings GmbH to bear their own costs and pay those of the Applicant. |

Pleas in law

| — | Infringement of Article 47(2) of Regulation No 2017/1001; |

| — | Infringement of Article 8(1)(b) of Regulation No 2017/1001. |

[Top](#document2)